CNTX — Context Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Context Therapeutics Inc (CNTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.33% (2025 Q3)
Avg. % of fund
1.91%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 10,679,391 -4,026,491 -27.4% 1.80% $15.7M $1.47
2025 Q3 UNCHANGED 14,705,882 — 0% 2.33% $14.2M $0.97
2025 Q2 UNCHANGED 14,705,882 — 0% 1.67% $9.6M $0.65
2025 Q1 UNCHANGED 14,705,882 — 0% 1.55% $9.0M $0.61
2024 Q4 INITIATED 14,705,882 — — 2.19% $15.4M $1.05
% of Fund (quarterly)    CNTX price (monthly, adj. close)

Other funds also holding CNTX

As of 2025 Q4 — sorted by position size

Avidity Partners Management LP 3Y 2.33% GREAT POINT PARTNERS LLC 3Y 7Y 2.23% Blue Owl Capital Holdings LP 3Y 0.82% CAXTON CORP 3Y 7Y 0.63% Sio Capital Management, LLC 3Y 7Y 0.31% Deep Track Capital, LP 3Y 0.19% Velan Capital Investment Management LP 3Y 0.09% ADAR1 Capital Management, LLC 0.04% Blackstone Inc. 3Y 7Y 0.01% Clear Harbor Asset Management, LLC 3Y 7Y 0.01%
← Back to MPM BioImpact LLC Holdings